Ceruvia Lifesciences
  • About Us
  • Research & Development
  • Research
  • News
  • Investors
  • Contact Us
Select Page
Ceruvia Lifesciences Drug Trials Work To Turn Psychedelic Research Into Medicine for OCD, Headache Disorders

Ceruvia Lifesciences Drug Trials Work To Turn Psychedelic Research Into Medicine for OCD, Headache Disorders

by ceruvia-dev | Aug 2, 2021 | Uncategorized

Ceruvia Lifesciences Drug Trials Work To Turn Psychedelic Research Into Medicine for OCD, Headache Disorders Synthetic psilocybin and BOL-148 — a non-psychedelic LSD derivative — appear to produce better results than current treatments. Ceruvia Lifesciences is...
Ceruvia Lifesciences logo
  • Follow
  • Follow
  • Follow

15 East Putnam Avenue, Suite #413
Greenwich, CT 06830

investors@ceruvialifesciences.com

About Us

  • About Ceruvia Lifesciences
  • Our Team
  • Collaborators & Partners
  • Scientific Advisors

Research & Development

  • Development Pipeline
  • Development Milestones
  • Publications
  • LSD Program

Investors

  • Downloads
  • Investor Relations
  • Media Kit
  • Contact Us

Resources

  • Clusterbusters
  • Use of Psilocybin
  • Headache Disorders
  • Obsessive Compulsive Disorder

PR & News

  • Latest PR & News

Ceruvia Lifesciences researches, develops, and manufactures neurotransformational medicines to deliver meaningful relief to patients suffering from challenging, hard-to-treat headaches and psychiatric disorders.

Copyright © Ceruvia Lifesciences 2021-2023. Privacy Policy | Terms of Service

All rights reserved.